Results 161 to 170 of about 11,060 (223)

Outcomes of functional ventricular tachycardia ablation vs. medical therapy in Chagas cardiomyopathy patients with implantable cardioverter-defibrillators: a competing risks analysis. [PDF]

Europace
Silva GA, Wilnes B, Castello-Branco B, da Silva JLP, Mayrink MP, França AT, França MRQ, Fonseca IMG, Castro de Miranda R, Nunes MDCP, Carmo AAL.   +10 more
europepmc   +1 more source

Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide registry-based cohort study. [PDF]

Cardiovasc Diabetol
Zhou Y, Rautio E, Näsman P, Gudbjörnsdottir S, Gadler F, Rydén L, Wodaje T, Mellbin LG.   +7 more
europepmc   +1 more source

Contemporary Use of Implantable Cardioverter-Defibrillators in the Era of 4-Pillar Heart Failure Therapy---an International Survey. [PDF]

CJC Open
Vandenberk B, Sandhu RK, Ezekowitz J, Chew DS.   +3 more
europepmc   +1 more source

Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy. [PDF]

Circ Arrhythm Electrophysiol
Abdelfattah OM, Sayed A, Al-Jwaid A, Hassan A, Abu Jazar D, Narayanan A, Link MS, Martinez MW.   +7 more
europepmc   +1 more source